Research progress of neoadjuvant chemotherapy for esophageal squamous cell carcinoma / 中华消化外科杂志
Chinese Journal of Digestive Surgery
;
(12): 604-606, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-752989
ABSTRACT
China is a high risk region of esophageal cancer in the world,and 95% of the esophageal cancer is the squamous cell carcinoma.Surgery is the main therapy for esophageal squamous cell carcinoma,however,the efficacy of single surgery for locally advanced esophageal squamous cell carcinoma is unsatisfactory.Compared with postoperative adjuvant treatment,neoadjuvant chemotherapy may reduce tumor volume,increase surgical resectability,eliminate subclinical metastases,prolong survival time and improve prognosis of patients with esophageal squamous cell carcinoma.Through combining recent evidence-based medicine,the authors review research progress of new adjuvant chemotherapy for esophageal squamous cell carcinoma.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Digestive Surgery
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS